Filings
Finds words inside filing documents. Searching HAEMONETICS CORP's filings · 32 documents indexed.
14 documents · 35 matches
-
HAE HAEMONETICS CORP 10-K 2026-05-20
Item 1A. Risk Factors
tariffs, potential changes or pauses to such tariffs, tariff levels, and whether further additional tariffs or other retaliatory actions may be imposed10 matches in this document -
HAE HAEMONETICS CORP 10-Q 2026-11-05
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariff refunds received, the continued transformation of the product portfolio to higher margin offerings and the absence of fair value2 matches in this document -
HAE HAEMONETICS CORP 8-K 2026-11-05
tariffs refunded, the continued transformation of the product portfolio to higher-margin offerings and the absence of amortization of fair3 matches in this document -
HAE HAEMONETICS CORP 10-Q 2026-08-06
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
similar laws in other jurisdictions, as well as the impact of U.S. and foreign export and import restrictions and tariffs;1 match in this document -
HAE HAEMONETICS CORP 8-K 2026-08-06
tariff policies and inflationary pressures; regulatory uncertainties, including in the receipt or timing of regulatory approvals, and the impact of changes1 match in this document -
HAE HAEMONETICS CORP 8-K 2026-06-05
tariff policies and inflationary pressures; regulatory uncertainties, including in the receipt or timing of regulatory approvals, and the impact of changes1 match in this document -
HAE HAEMONETICS CORP 8-K 2026-05-07
adjusted gross margin percentage were less favorable mix and impacts from tariffs, partially offset by higher volume and pricing benefits.3 matches in this document -
HAE HAEMONETICS CORP 10-Q 2026-02-05
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
similar laws in other jurisdictions, as well as the impact of U.S. and foreign export and import restrictions and tariffs;1 match in this document -
HAE HAEMONETICS CORP 8-K 2026-02-05
tariff policies and inflationary pressures; regulatory uncertainties, including in the receipt or timing of regulatory approvals, and the impact of changes1 match in this document -
HAE HAEMONETICS CORP 10-Q 2025-11-06
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
similar laws in other jurisdictions, as well as the impact of U.S. and foreign export and import restrictions and tariffs;1 match in this document -
HAE HAEMONETICS CORP 8-K 2025-11-06
tariff policies and inflationary pressures; regulatory uncertainties, including in the receipt or timing of regulatory approvals, and the impact of changes1 match in this document -
HAE HAEMONETICS CORP 10-Q 2025-08-07
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
similar laws in other jurisdictions, as well as the impact of U.S. and foreign export and import restrictions and tariffs;1 match in this document -
HAE HAEMONETICS CORP 8-K 2025-08-07
tariff policies and inflationary pressures; regulatory uncertainties, including in the receipt or timing of regulatory approvals, and the impact of changes1 match in this document -
HAE HAEMONETICS CORP 10-K 2025-05-21
Item 1. Business
tariffs, interest rates, monetary policy, exchange rates and geopolitical developments, which could adversely impact the costs associated with our manufacturing8 matches in this document
Page 1 of 1 · 14 documents